Related Experiment Videos
Hepatitis C and porphyria cutanea tarda
J C English1, M F Peake, L E Becker
1Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas 78234-6200, USA.
Cutis
|June 1, 1996
Summary
Porphyria cutanea tarda (PCT) is linked to reduced uroporphyrinogen decarboxylase (UPD) activity. Hepatitis C virus (HCV) infection is a newly identified factor that can trigger PCT, necessitating screening and monitoring for affected individuals.
Area of Science:
- Biochemistry
- Hepatology
- Dermatology
Background:
- Porphyria cutanea tarda (PCT) results from decreased uroporphyrinogen decarboxylase (UPD) activity.
- Various factors can precipitate PCT in susceptible individuals.
- Hepatitis C virus (HCV) is a recently identified potential trigger for PCT.
Observation:
- HCV infection, a blood-borne RNA virus, is implicated in inducing PCT.
- The precise mechanism of HCV-induced PCT remains unclear.
- HCV-associated PCT mirrors the clinical, laboratory, and histopathologic features of other PCT forms.
Findings:
- HCV infection can manifest as PCT.
- PCT presentation warrants investigation for HCV infection.
- HCV patients require monitoring for PCT development.
Implications:
- Clinicians should serologically test PCT patients for HCV antibodies.
- HCV patients should be monitored for PCT signs and symptoms.
- Understanding the link between HCV and PCT aids in diagnosis and management.